Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass.
Minerva Anestesiol 2010;76(8):584-591.
NATA Rating :
Review by : K. Holte
Albumin versus various colloids including several HES preparations has been evaluated in many recent trials in cardiopulmonary bypass. This trial, reporting no difference between albumin and HES 130/0.4 on coagulation variables, blood loss and immunological activity does not add any new information to the body of evidence already present in the area.
– Kathrine Holte